478 related articles for article (PubMed ID: 34641857)
1. Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy.
Iranpour S; Bahrami AR; Nekooei S; Sh Saljooghi A; Matin MM
J Nanobiotechnology; 2021 Oct; 19(1):314. PubMed ID: 34641857
[TBL] [Abstract][Full Text] [Related]
2. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
3. Using magnetic mesoporous silica nanoparticles armed with EpCAM aptamer as an efficient platform for specific delivery of 5-fluorouracil to colorectal cancer cells.
Kamil Mohammad Al-Mosawi A; Bahrami AR; Nekooei S; Saljooghi AS; Matin MM
Front Bioeng Biotechnol; 2022; 10():1095837. PubMed ID: 36686226
[No Abstract] [Full Text] [Related]
4. A potent multifunctional ZIF-8 nanoplatform developed for colorectal cancer therapy by triple-delivery of chemo/radio/targeted therapy agents.
Iranpour S; Bahrami AR; Dayyani M; Saljooghi AS; Matin MM
J Mater Chem B; 2024 Jan; 12(4):1096-1114. PubMed ID: 38229578
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of elesclomol using a magnetic mesoporous platform improves prostate cancer treatment both in vitro and in vivo.
Tarin M; Babaei M; Eshghi H; Matin MM; Saljooghi AS
Talanta; 2024 Apr; 270():125539. PubMed ID: 38141466
[TBL] [Abstract][Full Text] [Related]
6. Mesoporous silica nanoparticles combining Au particles as glutathione and pH dual-sensitive nanocarriers for doxorubicin.
Xu S; Li Y; Chen Z; Hou C; Chen T; Xu Z; Zhang X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():258-264. PubMed ID: 26652372
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
[TBL] [Abstract][Full Text] [Related]
8. EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer.
Li Y; Duo Y; Bao S; He L; Ling K; Luo J; Zhang Y; Huang H; Zhang H; Yu X
Int J Nanomedicine; 2017; 12():6239-6257. PubMed ID: 28894364
[TBL] [Abstract][Full Text] [Related]
9. Pegylated magnetic mesoporous silica nanoparticles decorated with AS1411 Aptamer as a targeting delivery system for cytotoxic agents.
Sakhtianchi R; Darvishi B; Mirzaie Z; Dorkoosh F; Shanehsazzadeh S; Dinarvand R
Pharm Dev Technol; 2019 Nov; 24(9):1063-1075. PubMed ID: 30654677
[TBL] [Abstract][Full Text] [Related]
10. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M
Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery system using silica nanoparticles coated with chitosan and AS1411 for combination therapy of doxorubicin and antimiR-21.
Khatami F; Matin MM; Danesh NM; Bahrami AR; Abnous K; Taghdisi SM
Carbohydr Polym; 2021 Aug; 266():118111. PubMed ID: 34044928
[TBL] [Abstract][Full Text] [Related]
12. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.
Tran VA; Vo VG; Shim K; Lee SW; An SSA
Int J Nanomedicine; 2020; 15():7667-7685. PubMed ID: 33116494
[TBL] [Abstract][Full Text] [Related]
13. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
[TBL] [Abstract][Full Text] [Related]
14. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
[TBL] [Abstract][Full Text] [Related]
15. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
16. In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice.
Ding Z; Wang D; Shi W; Yang X; Duan S; Mo F; Hou X; Liu A; Lu X
Int J Nanomedicine; 2020; 15():8383-8400. PubMed ID: 33149582
[TBL] [Abstract][Full Text] [Related]
17. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of theranostic epithelial cell adhesion molecule targeted mesoporous silica nanoparticle with gold gatekeeper for hepatocellular carcinoma.
Babaei M; Abnous K; Taghdisi SM; Amel Farzad S; Peivandi MT; Ramezani M; Alibolandi M
Nanomedicine (Lond); 2017 Jun; 12(11):1261-1279. PubMed ID: 28520529
[TBL] [Abstract][Full Text] [Related]
19. Hybrid nanoreservoirs based on dextran-capped dendritic mesoporous silica nanoparticles for CD133-targeted drug delivery.
Zahiri M; Babaei M; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
J Cell Physiol; 2020 Feb; 235(2):1036-1050. PubMed ID: 31276199
[TBL] [Abstract][Full Text] [Related]
20. An RGD-modified hollow silica@Au core/shell nanoplatform for tumor combination therapy.
Li X; Xing L; Hu Y; Xiong Z; Wang R; Xu X; Du L; Shen M; Shi X
Acta Biomater; 2017 Oct; 62():273-283. PubMed ID: 28823719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
